FDC-P1 myeloid cells engineered to express fibroblast growth factor receptor 1 proliferate and differentiate in the presence of fibroblast growth factor and heparin
about
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical applicationIncreased postischemic brain injury in mice deficient in uracil-DNA glycosylase.A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor.High-efficiency identification of genes by functional analysis from a retroviral cDNA expression library.Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
P2860
FDC-P1 myeloid cells engineered to express fibroblast growth factor receptor 1 proliferate and differentiate in the presence of fibroblast growth factor and heparin
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
FDC-P1 myeloid cells engineere ...... last growth factor and heparin
@en
type
label
FDC-P1 myeloid cells engineere ...... last growth factor and heparin
@en
prefLabel
FDC-P1 myeloid cells engineere ...... last growth factor and heparin
@en
P2860
P356
P1476
FDC-P1 myeloid cells engineere ...... last growth factor and heparin
@en
P2860
P304
P356
10.1073/PNAS.89.8.3315
P407
P577
1992-04-01T00:00:00Z